CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 270,000 shares at $16.25 ($4,387,500)
- 4 Open-market buy 10% owner bought 22,771 shares at an average $15.50 ($352,978)
- 4 Open-market sale 10% owner sold 240,000 shares at $16.00 ($3,840,000)
- 4 Open-market buy 10% owner bought 400,000 shares at $16.00 ($6,400,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 5,487 shares at an average $17.40 ($95,455)
- 4 Open-market buy 10% owner bought 8,150 shares at an average $17.79 ($144,979)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 433,333 shares at $15.00 ($6,499,995)
- 4 Conversion Chief Scientific Officer acquired 4,124 shares (conversion)
- 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
Page 7 of 8 · 158 filings